ID

28930

Beschrijving

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00552409

Link

https://clinicaltrials.gov/show/NCT00552409

Trefwoorden

Versies (1)
  1. 17-02-18 17-02-18 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

17 februari 2018

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Diabetes Mellitus NCT00552409

Engels

Eligibility Diabetes Mellitus NCT00552409

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of type 2 diabetes mellitus
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
urine albumin-creatinine ratio 30-1000 mg/g
Beschrijving

Urine albumin/creatinine ratio measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0455271
estimated glomerular filtration rate greater than or equal to 60 ml/min
Beschrijving

Estimated Glomerular Filtration Rate

Datatype

boolean

Alias
UMLS CUI [1]
C3811844
treatment with angiotensin converting enzyme inhibitor and/or angiotensin ii receptor blocker for greater than or equal to 6 months, with a stable dose for greater than or equal to 3 months
Beschrijving

Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Angiotensin-Converting Enzyme Inhibitors Dose Stable | Angiotensin II receptor antagonist Dose Stable

Datatype

boolean

Alias
UMLS CUI [1]
C0003015
UMLS CUI [2]
C0521942
UMLS CUI [3,1]
C0003015
UMLS CUI [3,2]
C0178602
UMLS CUI [3,3]
C0205360
UMLS CUI [4,1]
C0521942
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
blood pressure less than 140/90 (assessed while taking medications)
Beschrijving

Blood pressure determination | Intake Pharmaceutical Preparations

Datatype

boolean

Alias
UMLS CUI [1]
C0005824
UMLS CUI [2,1]
C1512806
UMLS CUI [2,2]
C0013227
hemoglobin a1c less than 9% (assessed while taking medications)
Beschrijving

Glucohemoglobin measurement | Intake Pharmaceutical Preparations

Datatype

boolean

Alias
UMLS CUI [1]
C0202054
UMLS CUI [2,1]
C1512806
UMLS CUI [2,2]
C0013227
25-hydroxyvitamin d less than 30 ng/ml
Beschrijving

25-Hydroxyvitamin D Measurement

Datatype

boolean

Alias
UMLS CUI [1]
C2984945
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior dialysis or kidney transplantation
Beschrijving

Dialysis | Kidney Transplantation

Datatype

boolean

Alias
UMLS CUI [1]
C0011946
UMLS CUI [2]
C0022671
known cause of albuminuria other than diabetes
Beschrijving

Cause Albuminuria | Exception Diabetes

Datatype

boolean

Alias
UMLS CUI [1,1]
C0015127
UMLS CUI [1,2]
C0001925
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0011847
planning to leave the area within 12 months
Beschrijving

Relocation of home Planned

Datatype

boolean

Alias
UMLS CUI [1,1]
C2699029
UMLS CUI [1,2]
C1301732
life expectancy less than 12 months
Beschrijving

Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
participation in another clinical trial within 6 months
Beschrijving

Study Subject Participation Status

Datatype

boolean

Alias
UMLS CUI [1]
C2348568
osteoporosis or other established indication for vitamin d therapy
Beschrijving

Osteoporosis | Indication Established Vitamin D supplement therapy

Datatype

boolean

Alias
UMLS CUI [1]
C0029456
UMLS CUI [2,1]
C3146298
UMLS CUI [2,2]
C0443211
UMLS CUI [2,3]
C0420176
vitamin d3 supplement intake greater than 400 iu/day at screening visit
Beschrijving

Vitamin D3 Supplement U/day

Datatype

boolean

Alias
UMLS CUI [1,1]
C3265062
UMLS CUI [1,2]
C2348609
UMLS CUI [1,3]
C0456683
history of nephrolithiasis
Beschrijving

Nephrolithiasis

Datatype

boolean

Alias
UMLS CUI [1]
C0392525
serum calcium greater than 10.2 mg/dl
Beschrijving

Serum calcium measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0728876
dementia, not fluent in english, or unable to provide informed consent without proxy respondent
Beschrijving

Dementia | Lacking Able to speak fluently English Language | Informed Consent Unable

Datatype

boolean

Alias
UMLS CUI [1]
C0497327
UMLS CUI [2,1]
C0332268
UMLS CUI [2,2]
C0564241
UMLS CUI [2,3]
C0376245
UMLS CUI [3,1]
C0021430
UMLS CUI [3,2]
C1299582
incontinent of urine
Beschrijving

Urinary Incontinence

Datatype

boolean

Alias
UMLS CUI [1]
C0042024
failure to take greater than or equal to 80% of placebo pills during study run-in
Beschrijving

Intake Placebo Pills Percentage failed

Datatype

boolean

Alias
UMLS CUI [1,1]
C1512806
UMLS CUI [1,2]
C1696465
UMLS CUI [1,3]
C0994475
UMLS CUI [1,4]
C0439165
UMLS CUI [1,5]
C0231175
Terug naar het begin van de pagina

Similar models

Eligibility Diabetes Mellitus NCT00552409

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
clinical diagnosis of type 2 diabetes mellitus
boolean
C0011860 (UMLS CUI [1])
Urine albumin/creatinine ratio measurement
Item
urine albumin-creatinine ratio 30-1000 mg/g
boolean
C0455271 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
estimated glomerular filtration rate greater than or equal to 60 ml/min
boolean
C3811844 (UMLS CUI [1])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist | Angiotensin-Converting Enzyme Inhibitors Dose Stable | Angiotensin II receptor antagonist Dose Stable
Item
treatment with angiotensin converting enzyme inhibitor and/or angiotensin ii receptor blocker for greater than or equal to 6 months, with a stable dose for greater than or equal to 3 months
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
C0003015 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C0205360 (UMLS CUI [3,3])
C0521942 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Blood pressure determination | Intake Pharmaceutical Preparations
Item
blood pressure less than 140/90 (assessed while taking medications)
boolean
C0005824 (UMLS CUI [1])
C1512806 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
Glucohemoglobin measurement | Intake Pharmaceutical Preparations
Item
hemoglobin a1c less than 9% (assessed while taking medications)
boolean
C0202054 (UMLS CUI [1])
C1512806 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
25-Hydroxyvitamin D Measurement
Item
25-hydroxyvitamin d less than 30 ng/ml
boolean
C2984945 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Dialysis | Kidney Transplantation
Item
prior dialysis or kidney transplantation
boolean
C0011946 (UMLS CUI [1])
C0022671 (UMLS CUI [2])
Cause Albuminuria | Exception Diabetes
Item
known cause of albuminuria other than diabetes
boolean
C0015127 (UMLS CUI [1,1])
C0001925 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0011847 (UMLS CUI [2,2])
Relocation of home Planned
Item
planning to leave the area within 12 months
boolean
C2699029 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy less than 12 months
boolean
C0023671 (UMLS CUI [1])
Study Subject Participation Status
Item
participation in another clinical trial within 6 months
boolean
C2348568 (UMLS CUI [1])
Osteoporosis | Indication Established Vitamin D supplement therapy
Item
osteoporosis or other established indication for vitamin d therapy
boolean
C0029456 (UMLS CUI [1])
C3146298 (UMLS CUI [2,1])
C0443211 (UMLS CUI [2,2])
C0420176 (UMLS CUI [2,3])
Vitamin D3 Supplement U/day
Item
vitamin d3 supplement intake greater than 400 iu/day at screening visit
boolean
C3265062 (UMLS CUI [1,1])
C2348609 (UMLS CUI [1,2])
C0456683 (UMLS CUI [1,3])
Nephrolithiasis
Item
history of nephrolithiasis
boolean
C0392525 (UMLS CUI [1])
Serum calcium measurement
Item
serum calcium greater than 10.2 mg/dl
boolean
C0728876 (UMLS CUI [1])
Dementia | Lacking Able to speak fluently English Language | Informed Consent Unable
Item
dementia, not fluent in english, or unable to provide informed consent without proxy respondent
boolean
C0497327 (UMLS CUI [1])
C0332268 (UMLS CUI [2,1])
C0564241 (UMLS CUI [2,2])
C0376245 (UMLS CUI [2,3])
C0021430 (UMLS CUI [3,1])
C1299582 (UMLS CUI [3,2])
Urinary Incontinence
Item
incontinent of urine
boolean
C0042024 (UMLS CUI [1])
Intake Placebo Pills Percentage failed
Item
failure to take greater than or equal to 80% of placebo pills during study run-in
boolean
C1512806 (UMLS CUI [1,1])
C1696465 (UMLS CUI [1,2])
C0994475 (UMLS CUI [1,3])
C0439165 (UMLS CUI [1,4])
C0231175 (UMLS CUI [1,5])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial